Preliminary Results of a Prospective Randomized Trial Comparing Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy With Radiotherapy Alone in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma in Endemic Regions of China

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 5, 2008, Pages 1356-1364

  Chen, Yong ^a   Liu, Meng Zhong ^a   Liang, Shao Bo ^a   Zong, Jing Feng ^c   Mao, Yan Ping ^a   Tang, Ling Long ^a   Guo, Ying ^a   Lin, Ai Hua ^b   Zeng, Xiang Fa ^a   Ma, Jun ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c FUJIAN PROVINCIAL TUMOR HOSPITAL   (China)

Author keywords

Adjuvant chemotherapy; Chinese; Concurrent chemotherapy; Nasopharyngeal carcinoma; Prospective randomized trial

Indexed keywords

BIOTECHNOLOGY; CHEMOTHERAPY; ELECTROTHERAPEUTICS; EMERGENCY VEHICLES; FLUORESCENT SCREENS; PLATINUM COMPOUNDS; RADIOTHERAPY; STANDARDS; TELEVISION PICTURE TUBES;

ADJUVANT CHEMOTHERAPY; CHEMORADIOTHERAPY; CHINESE; CONCURRENT CHEMORADIOTHERAPY; CONCURRENT CHEMOTHERAPY; CONCURRENT CISPLATIN; NASOPHARYNGEAL CARCINOMA; PROSPECTIVE RANDOMIZED TRIAL; RADIOTHERAPY ALONE; RANDOMIZED TRIAL;

HEALTH;

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CHINA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; ENDEMIC DISEASE; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT REFUSAL; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHINA; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT FAILURE;

EID: 47149084927     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.12.028     Document Type: Article

References (37)

1. Chua D.T., Sham J.S.T., Kwong D.L., et al. Treatment outcome after radiotherapy alone for patients with Stage I-II nasopharyngeal carcinoma. Cancer 98 (2003) 74-80
2. Ma J., Mai H.Q., Hong M.H., et al. Is the 1997 AJCC Staging System for nasopharyngeal carcinoma prognostically useful for Chinese patient population. Int J Radiat Oncol Biol Phys 50 (2001) 1181-1189
3. Heng D.M.K., Wee J., Fong K.W., et al. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer 86 (1999) 1912-1920
4. Teo P., Yu P., Lee W.Y., et al. Significant prognosticators after primary radiotherapy in 903 nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 36 (1996) 291-304
5. Lee A., Poon Y., Foo W., et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: Overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 23 (1992) 261-270
6. Nacy L., Ping X., Jeanne M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys 53 (2002) 12-19
7. Kam M.K., Teo P.M., Chau R.M., et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience. Int J Radiat Oncol Biol Phys 60 (2004) 1440-1450
8. Kwong D.L., Sham J.S., Leung L.H., et al. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 64 (2006) 374-381
9. Chan A.T., Teo P.M., and Johnson P.J. Nasopharyngeal carcinoma. Ann Oncol 13 (2002) 1007-1015
10. Teo P.M.L., Leung S.F., Yu P., et al. A comparison of Ho's, International Union Against Cancer, and American Joint Committee Stage Classifications for nasopharyngeal carcinoma. Cancer 67 (1991) 434-439
11. Min H.Q., Hong M.H., Ma J., et al. A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Oncol Biol Phys 30 (1994) 1037-1042
12. Decker D.A., Drelichman A., and Al-Sarraf M. Chemotherapy for nasopharyngeal carcinoma: A ten-year experience. Cancer 52 (1983) 602-605
13. Al-Sarraf M. Chemotherapeutic management of head and neck cancer. Cancer Metast Rev 6 (1987) 191-198
14. Ma J., Mai H., Hong M.H., et al. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 19 (2001) 1350-1357
15. Chua D.T.T., Sham J.S.T., Choy D., et al. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing Cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma. Cancer 83 (1998) 2270-2283
16. International Nasopharynx Cancer Study Group. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (Cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV undifferentiated nasopharyngeal carcinoma: a positive effect on progression free survival. Int J Radiat Oncol Biol Phys 35 (1996) 463-469
17. Chan A.T.C., Teo P.M.L., Leung T.W.T., et al. A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 33 (1995) 569-577
18. Rossi A., Molinari R., Boracchi P., et al. Adjuvant chemotherapy with vincristine, cyclophosphamide and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: Results of a 4 year multi-center randomized study. J Clin Oncol 6 (1988) 1401-1410
19. Al-Sarraf M., LeBlanc M., Giri P.G.S., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup Study 00-99. J Clin Oncol 16 (1998) 1310-1317
20. Chua D.T.T., Sham J.S.T., Au G.K.H., et al. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in Chinese patients: Results of a matched cohort analysis. Int J Radiat Oncol Biol Phys 53 (2002) 334-343
21. Marks J.E., Philips J.L., and Menck H.R. The National Cancer Data Base Report on the relationship of race and national origin to the histology of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 83 (1998) 582-588
22. Edward C., David P., Brian O., et al. Radiotherapy alone in patients with advanced nasopharyngeal cancer: Comparison with an intergroup study. Is combined modality treatment really necessary?. Radiother Oncol 63 (2002) 269-274
23. Jun M., Li-Zhi L., Ling-Long T., et al. Retropharyngeal lymphadenopathy in nasopharyngeal carcinoma: Prognostic value and staging categories. Clin Cancer Res 13 (2007) 1445-1452
24. Tsao S.Y. Technical details for radiotherapy delivery. In: van Hasselt C.A., and Gibb A.G. (Eds). Nasopharyngeal carcinoma (1991), The Chinese University Press, Hong Kong 207-208
25. Miller A.B., Hoogstraten B., Staquet M., et al. Reporting results of cancer treatment. Cancer 47 (1981) 207-214
26. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
27. Cox D.R. Regression models and life tables. J R Stat Soc B 34 (1972) 187-220
28. Wee J., Tan E.H., Tai B.C., et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23 (2005) 6730-6738
29. Lee A., Lau W.H., Tung S.Y., et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23 (2005) 6966-6975
30. Biedermann B., Landmann C., Kann R., et al. Combined chemoradiotherapy with daily low-dose cisplatin in locally advanced inoperable non-small cell lung cancer. Radiother Oncol 56 (2000) 169-173
31. Bachaud J.M., Cohen-Jonathan E., Alzieu C., et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial. Int J Radiat Oncol Biol Phys 36 (1996) 999-1004
32. Chan A.T.C., Teo P.M.L., Ngan R.K.C., et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial. J Clin Oncol 20 (2002) 2038-2044
33. Chan A.T., Leung S.F., Ngan R.K., et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 97 (2005) 536-539
34. Browman G.P., and Cronin L. Standard chemotherapy in squamous cell head and neck cancer: What we have learned from randomized trials. Semin Oncol 21 (1994) 311-319
35. Bertrand B., Helene A., Jean B., et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 64 (2006) 47-56
36. Lu T.X., Mai W.Y., Teh B.S., et al. Important prognostic factors in patients with skull base erosion from nasopharyngeal carcinoma after radiotherapy. Int J Radiat Oncol Biol Phys 51 (2001) 589-598
37. Gearaa F.B., Sanguineti G., Tuckerb S.L., et al. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of distant metastasis and survival. Radiother Oncol 43 (1997) 53-61